While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...] …
Category: Pharma Industry
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The drug industry is bracing for the Trump administration’s planned tariffs on pharmaceutical products and ingredients, warning of supply chain [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Department of Health and Human Services (HHS) is continuing its pushback against drugmaker attempts to unilaterally convert upfront [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
An influential drug industry trade group on Friday sued Utah over its 340B contract pharmacy access law, marking the third [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Hospital and health center leaders are pushing back against President Donald Trump’s (R) new executive order, criticizing its controversial 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Merck is lifting its 340B contract pharmacy restrictions in three more states that have recently enacted contract pharmacy access laws—while [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
News Alert
Trump Revives Controversial 340B Rule for Insulin, EpiPens in Sweeping Health Care Executive Order
President Donald Trump (R) last night issued a wide-ranging health care executive order that revives a controversial 340B policy from [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
State legislators in Oregon and Oklahoma voted yesterday to advance separate bills that would prohibit drugmakers from placing 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant AbbVie recently filed lawsuits against the states of Nebraska, North Dakota and South Dakota over their newly enacted [...] …